Scarica l'app Stockscreener
1.27
3.79%
-0.05
Dopo l'orario di chiusura:
1.27
Precedente Chiudi:
$1.32
Aprire:
$1.35
Volume 24 ore:
51,355
Relative Volume:
0.27
Capitalizzazione di mercato:
$58.24M
Reddito:
$124.00K
Utile/perdita netta:
$-10.78M
Rapporto P/E:
-5.1922
EPS:
-0.2446
Flusso di cassa netto:
$-7.36M
1 W Prestazione:
+1.60%
1M Prestazione:
-15.33%
6M Prestazione:
-29.44%
1 anno Prestazione:
-31.35%
Intervallo 1D:
$1.26
$1.3685
Intervallo di 1 settimana:
$1.25
$1.5699
Portata 52W:
$1.00
$3.22
Entera Bio Ltd Stock (ENTX) Company Profile
Nome
Entera Bio Ltd
Settore
Industria
Telefono
972-2-532-7151
Indirizzo
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Compare ENTX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ENTX
Entera Bio Ltd
|
1.27 | 58.24M | 124.00K | -10.78M | -7.36M | -0.2446 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-03-22 | Iniziato | Aegis Capital | Buy |
Entera Bio Ltd Borsa (ENTX) Ultime notizie
Entera Takes Final Step Towards Phase 3, Accelerating Timeline f - GuruFocus
Performance Recap: Is Entera Bio Ltd stock risky to hold now2026 Highlights & Daily Market Momentum Tracking - baoquankhu1.vn
Entera Takes Final Step Towards Phase 3, Accelerating Timeline for First Oral Anabolic Osteoporosis Therapy - TipRanks
Entera Bio (NASDAQ:ENTX) Director Geno Germano Purchases 20,000 Shares - MarketBeat
Insider Buying: Geno Germano Acquires Additional Shares of Enter - GuruFocus
Insider Buying: Entera Bio (NASDAQ:ENTX) Director Buys 10,000 Shares of Stock - MarketBeat
Director Sean Ellis buys 10,000 Entera Bio (ENTX) shares on market - Stock Titan
What pushed Entera Bio (ENTX) to rally nearly 16% after hours - MSN
Entera Bio Moves Toward Phase 3 With Oral Therapy That Could Transform Osteoporosis Treatment (NASDAQ: ENTX) - TipRanks
Entera Bio (NASDAQ:ENTX) Stock Price Down 3%Here's What Happened - MarketBeat
Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis - Bitget
Entera Bio submits streamlined Phase 3 protocol for oral osteoporosis drug - Investing.com
Entera Bio Submits Streamlined Phase 3 Plan for EB613 - TipRanks
Entera Bio submits streamlined Phase 3 protocol for EB613, seeks 12-month hip BMD primary endpoint - TradingView
Entera Bio (NASDAQ: ENTX) refines EB613 Phase 3 osteoporosis trial timeline - Stock Titan
Entera Bio submits streamlined phase 3 protocol to initiate registrational program for EB613 in postmenopausal women with osteoporosis - marketscreener.com
First oral bone-building osteoporosis tablet set on path to Phase 3, results expected 2028 - Stock Titan
Enterprise value of Entera Bio Ltd. – HAM:5DT - TradingView
Debt to equity ratio of Entera Bio Ltd. – HAM:5DT - TradingView
ENTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ENTX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Short Bowel Syndrome Market: High-Growth Opportunities for Investors to 2034DelveInsight - openPR.com
Entera Bio to Participate in the Leerink Partners 2026 Global Healthcare Conference - GlobeNewswire
Entera Bio CEO to join Leerink 2026 healthcare fireside chat - Stock Titan
Buyback Watch: Is Entera Bio Ltd stock risky to hold nowTrade Ideas & Low Volatility Stock Suggestions - baoquankhu1.vn
Entera Bio Heads Toward Phase 3 With EB613 in a 200 Million-Woma - GuruFocus
Entera Bio Heads Toward Phase 3 With EB613 in a 200 Million-Woman Osteoporosis Market (NASDAQ: ENTX) - TipRanks
Nasdaq Moves: Is BHRPRB impacted by rising ratesJuly 2025 Opening Moves & AI Forecast for Swing Trade Picks - baoquankhu1.vn
ENTXEntera Bio Ltd Latest Stock News & Market Updates - Stock Titan
Will Entera Bio Ltd. stock see insider buyingJuly 2025 Pullbacks & Accurate Buy Signal Alerts - mfd.ru
Entera Bio names former Pfizer executive Geno Germano as board chair - MSN
What Pushed Entera Bio (ENTX) To Rally Nearly 16% After Hours - Finviz
Entera Bio (ENTX) director buys 5,000 shares in open market trade - Stock Titan
Is Entera Bio Ltd. a good stock for dollar cost averaging2025 Support & Resistance & Verified Technical Trade Signals - mfd.ru
Will Entera Bio Ltd. stock outperform growth indexesEarnings Summary Report & Free High Accuracy Swing Entry Alerts - mfd.ru
Is Entera Bio Ltd. stock risky to hold nowWeekly Investment Summary & Growth Oriented Trading Recommendations - mfd.ru
Aug Momentum: Can Entera Bio Ltd deliver consistent dividendsEarnings Growth Summary & Low Volatility Stock Suggestions - baoquankhu1.vn
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 - GlobeNewswire Inc.
Why Entera Bio Ltd. stock could rally in 2025Chart Signals & Expert Approved Momentum Trade Ideas - mfd.ru
ENTX Rallies As Insiders Buy Company Shares — Retail Hopes For ‘Exciting Days’ Ahead - Asianet Newsable
Will Entera Bio Ltd. stock gain from government policiesJuly 2025 Sentiment & High Conviction Investment Ideas - mfd.ru
Insider Buying: Steven Rubin Acquires Shares of Entera Bio Ltd (ENTX) - GuruFocus
Sean Ellis Buys 18,000 Shares of Entera Bio (NASDAQ:ENTX) Stock - MarketBeat
Entera Bio Shares Rise After Open Market Purchase By Board Members - Nasdaq
Entera Bio Ltd. Board Members and CEO Purchase Company Shares Amid Ongoing Development of Oral Therapies - Quiver Quantitative
Entera Bio insiders are buying more of their own shares on market - Stock Titan
Why Entera Bio Ltd. (5DT) stock is favored by hedge funds2025 Investor Takeaways & Accurate Trade Setup Notifications - mfd.ru
Entera Bio Names Geno Germano Independent Board Chairman - The Globe and Mail
Entera Bio appoints Geno Germano as board chairman By Investing.com - Investing.com South Africa
Entera Bio appoints former Pfizer executive Geno J. Germano as chairman of the board ahead of key milestones - marketscreener.com
Entera Bio Ltd: Geno J. Germano appointed as chairman of Entera Bio - marketscreener.com
Entera Bio Ltd Azioni (ENTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):